The detailed results are shown in Table S16 of the supplement, which summarizes all the discussed results for lower grade glioma, a type of tumor in which CXCR2 ligands negatively correlated with the count of MDSCs, cells that inhibit the anti-tumor response [67]. The gene discussed is CXCR2; the disease is central nervous system cancer.